Novel tricyclic compounds

The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Saved in:
Bibliographic Details
Main Authors ERICSSON, ANNA M, CALDERWOOD, DAVID J, LI, BIQIN C, FRIEDMAN, MICHAEL, FIAMENGO, BRYAN R, WALLACE, GRIER A, WANG, LU, WOLLER, KEVIN R, WISHART, NEIL, FRANK, KRISTINE E, GEORGE, DAWN M, JOSEPHSOHN, NATHAN S, GOEDKEN, ERIC R, STEWART, KENT D, VOSS, JEFFREY W, ARGIRIADI, MARIA A, MORYTKO, MICHAEL J
Format Patent
LanguageChinese
English
Published 16.09.2014
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
AbstractList The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Author FIAMENGO, BRYAN R
ARGIRIADI, MARIA A
LI, BIQIN C
WALLACE, GRIER A
STEWART, KENT D
FRANK, KRISTINE E
VOSS, JEFFREY W
FRIEDMAN, MICHAEL
GOEDKEN, ERIC R
GEORGE, DAWN M
MORYTKO, MICHAEL J
WISHART, NEIL
JOSEPHSOHN, NATHAN S
WANG, LU
WOLLER, KEVIN R
ERICSSON, ANNA M
CALDERWOOD, DAVID J
Author_xml – fullname: ERICSSON, ANNA M
– fullname: CALDERWOOD, DAVID J
– fullname: LI, BIQIN C
– fullname: FRIEDMAN, MICHAEL
– fullname: FIAMENGO, BRYAN R
– fullname: WALLACE, GRIER A
– fullname: WANG, LU
– fullname: WOLLER, KEVIN R
– fullname: WISHART, NEIL
– fullname: FRANK, KRISTINE E
– fullname: GEORGE, DAWN M
– fullname: JOSEPHSOHN, NATHAN S
– fullname: GOEDKEN, ERIC R
– fullname: STEWART, KENT D
– fullname: VOSS, JEFFREY W
– fullname: ARGIRIADI, MARIA A
– fullname: MORYTKO, MICHAEL J
BookMark eNrjYmDJy89L5WSQ9MsvS81RKCnKTK5MzslMVkjOzy3IL81LKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGhibGJhYmho7GxKgBAAqZJMo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW201434841A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW201434841A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:41:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW201434841A3
Notes Application Number: TW20143118323
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&CC=TW&NR=201434841A
ParticipantIDs epo_espacenet_TW201434841A
PublicationCentury 2000
PublicationDate 20140916
PublicationDateYYYYMMDD 2014-09-16
PublicationDate_xml – month: 09
  year: 2014
  text: 20140916
  day: 16
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies ABBVIE INC
RelatedCompanies_xml – name: ABBVIE INC
Score 3.045633
Snippet The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Novel tricyclic compounds
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140916&DB=EPODOC&locale=&CC=TW&NR=201434841A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTQ0tUgyNk7STTYzTtQFnYWpa5mclKibYgysvY0tgQ2KZNBuZF8_M49QE68I0wgmhizYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dg05vMjRTc3GydQ3wd_F3VnN2tg0JV_MLAssZm1iYGDoyM7CCmtGgc_Zdw5xAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizBI-uWXpeYogE7Ur0wGulIBtBocdClSsSiDoptriLOHLtCOeLiH4kPCEc4xFmNgAXb0UyUYFFLTzA3TTJIMjZKTDEEXgyUlmZiZpAFD0yAVfK6eJIMUbnOk8ElKM3CBOKB1DoZmMgwsJUWlqbLAyrQkSQ4cCgA5A3c1
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQsTQ0tUgyNk7STTYzTtQFnYWpa5mclKibYgysvY0tgQ2KZNBuZF8_M49QE68I0wgmhizYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dg05vMjRTc3GydQ3wd_F3VnN2tg0JV_MLAssZm1iYGDoyM7Cag07nBTWdwpxAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizBI-uWXpeYogE7Ur0wGulIBtBocdClSsSiDoptriLOHLtCOeLiH4kPCEc4xFmNgAXb0UyUYFFLTzA3TTJIMjZKTDEEXgyUlmZiZpAFD0yAVfK6eJIMUbnOk8EnKM3B6hPj6xPt4-nlLM3CBJEBrHgzNZBhYSopKU2WBFWtJkhw4RADznXoi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+tricyclic+compounds&rft.inventor=ERICSSON%2C+ANNA+M&rft.inventor=CALDERWOOD%2C+DAVID+J&rft.inventor=LI%2C+BIQIN+C&rft.inventor=FRIEDMAN%2C+MICHAEL&rft.inventor=FIAMENGO%2C+BRYAN+R&rft.inventor=WALLACE%2C+GRIER+A&rft.inventor=WANG%2C+LU&rft.inventor=WOLLER%2C+KEVIN+R&rft.inventor=WISHART%2C+NEIL&rft.inventor=FRANK%2C+KRISTINE+E&rft.inventor=GEORGE%2C+DAWN+M&rft.inventor=JOSEPHSOHN%2C+NATHAN+S&rft.inventor=GOEDKEN%2C+ERIC+R&rft.inventor=STEWART%2C+KENT+D&rft.inventor=VOSS%2C+JEFFREY+W&rft.inventor=ARGIRIADI%2C+MARIA+A&rft.inventor=MORYTKO%2C+MICHAEL+J&rft.date=2014-09-16&rft.externalDBID=A&rft.externalDocID=TW201434841A